Interpace Biosciences Inc organizacji Cena/wartość księgowa
Jaka jest wartość Cena/wartość księgowa organizacji Interpace Biosciences Inc?
Wartość Cena/wartość księgowa organizacji Interpace Biosciences Inc to -0.07
Jaka jest definicja Cena/wartość księgowa?
Wskaźnik ceny do sprzedaży(Price to book ratio) reprezentuje stosunek wartości akcji spółki do wartości księgowej na akcję.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Cena/wartość księgowa firm w Health Care sektor na NASDAQ w porównaniu do Interpace Biosciences Inc
Czym się zajmuję organizacja Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Firmy z cena/wartość księgowa podobne do Interpace Biosciences Inc
- Wartość Cena/wartość księgowa organizacji China Rundong Auto to -0.07
- Wartość Cena/wartość księgowa organizacji Uttam Value Steels to -0.07
- Wartość Cena/wartość księgowa organizacji Ferrellgas Partners to -0.07
- Wartość Cena/wartość księgowa organizacji Wheeler Real Estate Investment Trust Inc to -0.07
- Wartość Cena/wartość księgowa organizacji ION Geophysical Corp to -0.07
- Wartość Cena/wartość księgowa organizacji Invigor to -0.07
- Wartość Cena/wartość księgowa organizacji Interpace Biosciences Inc to -0.07
- Wartość Cena/wartość księgowa organizacji Federal National Mortgage Association to -0.07
- Wartość Cena/wartość księgowa organizacji Premier to -0.07
- Wartość Cena/wartość księgowa organizacji Bombay Rayon Fashions to -0.07
- Wartość Cena/wartość księgowa organizacji Supreme Infrastructure India to -0.07
- Wartość Cena/wartość księgowa organizacji AI Technology to -0.07
- Wartość Cena/wartość księgowa organizacji Sparta Commercial Services to -0.07